Clinical Trial Update: Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating cyclosporin A eye drops for Vernal keratoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vernal Keratoconjunctivitis

Drugs mentioned

• Cyclosporin A eye drop (cyclosporine)

Snippet

Sponsor: Campus Bio-Medico University | Conditions: Vernal Keratoconjunctivitis | Phase 3 | Status: COMPLETED